Kepler Cheuvreux disclosed Brenntag (ETR:BNR), hiking its price target to 52.00EUR earlier today
- Updated: September 29, 2016
Reporting a potential upside of 0.06%, Kepler Cheuvreux upped the price target of Brenntag (ETR:BNR) to 52.00EUR
On 09/29/2016, Kepler Cheuvreux released a statement on Brenntag (ETR:BNR) upped the target price from 0.00EUR to 52.00EUR that suggested an upside of 0.06%.
Having a price of 48.85EUR, Brenntag (ETR:BNR) traded 0.00% even on the day. With the last close up 0.00% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. BNR has recorded a 50-day average of 0.00EUR and a two hundred day average of 0.00EUR. Trade Volume held steady, with 0 shares of BNR changing hands on par with the typical 0
Recent Performance Chart
Brenntag has with a one year low of 0.00EUR and a one year high of 0.00EUR and has a market capitalization of 0 EUR.
General Company Details For Brenntag (ETR:BNR)
Brenntag AG is a Germany-based company active in the field of full-line chemical distribution. It provides business-to-business distribution solutions for industrial and specialty chemicals. The Company purchases and stores large-scale quantities of industrial and specialty chemicals and repackages them into smaller quantities. In addition, the Company also offers additional services, including delivery, product mixing, blending, repackaging, micronization and fine milling, inventory management and drum return handling, as well as technical and laboratory services for specialty chemicals. The Company offers its products to a range of market industries, such as adhesives, paints, oil & gas, food, water treatment, personal care and pharmaceuticals. The Company operates through a network with more than 450 locations in Europe, North and Latin America, and in the Asia Pacific region. Its subsidiaries include, among others, Quimicas Merono SL.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.